🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

Todos Aviação Tecnologia Aviação Executiva Negócios Desenvolvimento Web Empreendedorismo Comunidade Empresas Dicas ESG Caso de Sucesso Esportes Notícias Inteligência Artificial Eventos Investimentos IoT Marketing Meio Ambiente Sistemas ERP
119 notícias encontradas para "type"
Long-term exposure to air pollution linked to increased risk of Parkinson's disease
Long-term exposure to certain types of air pollution is linked to an increased risk of Parkinson's disease, Cambridge researchers have found in a critical review of the existing evidence.
Admin Recifes 15/07/2026 1
Decline in work productivity found 15 years before early-onset dementia diagnosis
People diagnosed with early-onset dementia had reduced work productivity up to 15 years before diagnosis, according to a study published in Neurology. Researchers also found the number of years of lower productivity varied depending on the type of dementia.
Admin Recifes 15/07/2026 1
Foto: Nataliya Vaitkevich / Pexels
GLP-1 agonists may help people with diabetes and long COVID, study in mice suggests
GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health benefits as well. Findings from experiments on mice, published in the Journal of Virology, suggest that the drugs may offer benefits to another patient popula
Admin Recifes 15/07/2026 2
New first-in-human study explores immune-engineered cell therapy approach for type 1 diabe
New first-in-human study explores immune-engineered cell therapy approach for type 1 diabe
New research presented at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an approach that could expand the potential of cell replacement therapy for type 1 diabetes by evaluating whether immune-engineered, allogeneic insulin-producing cells
Admin Recifes 15/07/2026 1
This unusual epigenetic modifier promotes certain cancers but suppresses others
This unusual epigenetic modifier promotes certain cancers but suppresses others
The epigenetic modifier MLL4 has an unassuming name—the 4, for instance, indicates it's just one in a family of such modifiers. But MLL4 is quite special: In a specific type of leukemia, it drives disease progression, while in solid tumors, it acts as a suppressor.
Admin Recifes 15/07/2026 2
Cancer evolution study reveals biology of glioma progression
Cancer evolution study reveals biology of glioma progression
A form of glioma, a type of brain cancer, tends to progress toward greater malignancy due to an increasing tendency of glioma cells to transform into immature, stem cell-like states, according to a study led by investigators at Weill Cornell Medicine, the New York Genome Center,
Admin Recifes 15/07/2026 1
Foto: Turgay Koca / Pexels
Novel microenvironment-targeted therapy for bone marrow recovery after injury
A healthy bone marrow (BM) produces nearly all types of cells in our blood. Many blood disorders occur when hematopoietic stem cells (HSCs) in the BM malfunction. Treatment with radiation or chemotherapy for many blood disorders and cancers can, as a side effect, deplete not only
Admin Recifes 15/07/2026 1
Forget GLP-1s—GLP-3s show promise in phase 3 weight loss and diabetes trial
Forget GLP-1s—GLP-3s show promise in phase 3 weight loss and diabetes trial
Phase 3 clinical trial results (TRANSCEND-T2D-1) published in The Lancet report that retatrutide, an investigational once-weekly injection for diabetes management, can significantly improve blood sugar levels and lead to substantial weight loss in people with Type 2 diabetes. The
Admin Recifes 15/07/2026 1
Foto: Google DeepMind / Pexels
Body's own cell-to-cell messaging packets studied as the basis for next-generation medicin
The Blood and Tissue Bank is studying how to therapeutically manufacture and use a type of nanoparticles released by the body's cells to communicate with one another, in one of the most promising fields of research for the therapies of the future. New medicines and advanced thera
Admin Recifes 15/07/2026 1
Why the fastest-growing Ebola outbreak in history is becoming more challenging
The Ebola outbreak in eastern Congo is now the fastest-growing one in history, and new challenges keep emerging even as work begins on a study of two badly needed treatments for a type of Ebola that currently has none.
Admin Recifes 15/07/2026 1
Dialing back stiffness may protect muscles in myotonic dystrophy
For decades, researchers studying myotonic dystrophy type 1 (DM1) have focused on the disease's underlying genetic cause: a mutation that produces a toxic form of RNA, disrupting the normal processing of thousands of genetic messages inside cells. While scientists have known this
Admin Recifes 15/07/2026 2
US study suggests GLP-1 RA drugs are associated with small increase in ischemic optic neur
US study suggests GLP-1 RA drugs are associated with small increase in ischemic optic neur
A target trial emulation found that people with type 2 diabetes who started glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy had a slightly higher risk of ischemic optic neuropathy (ION), a rare condition involving reduced blood flow to the optic nerve that can cause su
Admin Recifes 15/07/2026 2
← Anterior 1 … 4 5 6 … 10 Próximo →